RE-COV LTD.

Company number 14511049 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

RE-COV LTD. - Analysis Report

Company Number: 14511049

Analysis Date: 2025-07-20 18:17 UTC

Financial Health Assessment for RE-COV LTD. (as of 30 November 2024)


1. Financial Health Score: D

Explanation:
RE-COV LTD exhibits significant financial distress symptoms, primarily evident in persistent negative net current assets and shareholders’ funds. The company’s balance sheet shows increasing deficits year-on-year, indicating a troubled financial condition. While still operational and compliant with filing deadlines, the financial "vital signs" suggest it is far from a healthy state, requiring urgent attention to avoid further deterioration.


2. Key Vital Signs

Metric 2022 (£) 2023 (£) 2024 (£) Interpretation
Current Assets (5,518) (5,518) (6,546) Negative current assets indicate lack of liquid resources.
Current Liabilities Not shown Not shown 12,486 Rising short-term debts increase liquidity pressure.
Net Current Assets (5,518) (5,518) (19,032) Negative working capital worsened sharply; "symptom of distress".
Total Assets Less Current Liabilities (5,518) (5,518) (19,032) Negative net assets reflect insolvency on a balance sheet basis.
Shareholders Funds (5,518) (5,518) (19,032) Equity deficit shows accumulated losses eroding ownership value.

Additional Context:

  • No employees are recorded, implying a possibly non-operational or very early-stage business.
  • The sole director and 100% shareholder is Mr. Matthew Joseph Freaney, indicating centralized control.
  • The company is categorized as a micro-entity, limiting the scope of its financial complexity.

3. Diagnosis

Symptoms Analysis:

  • Negative Net Current Assets: The company’s inability to cover short-term liabilities with short-term assets is a critical warning sign. This "cash flow blockage" can lead to insolvency if not addressed.
  • Increasing Equity Deficit: The shareholder funds have deteriorated substantially in 2024, signaling ongoing losses or unaddressed liabilities. This is akin to a patient whose vital organs are underperforming.
  • No Employees and Micro Status: The lack of staff may suggest a company in the incubation phase or one that has ceased active trading, potentially limiting revenue generation capability.
  • No Audit Requirement: Being a micro-entity limits transparency and may mask operational issues not visible from the accounts alone.

Overall Financial Condition:
RE-COV LTD is currently in a financially distressed state, with net liabilities significantly exceeding assets. This condition is precarious and could lead to insolvency without intervention. The company’s "financial health" is fragile, and it is currently "on life support" in terms of liquidity and capital structure.


4. Recommendations

Immediate Actions:

  • Capital Injection: The director/shareholder should consider injecting additional funds to restore positive working capital and shore up equity, analogous to administering a vital transfusion to stabilize the patient.
  • Cost Management: Scrutinize and reduce any non-essential expenditures to conserve cash and improve liquidity.
  • Review Payables: Negotiate with creditors to extend payment terms or restructure liabilities to ease short-term financial pressure.
  • Business Model Assessment: Evaluate whether the current business activities (physical well-being services) are generating revenue or require strategic pivot to improve income streams.

Medium to Long-Term:

  • Prepare Cash Flow Forecasts: Develop detailed cash flow projections to anticipate future liquidity needs and prevent crisis episodes.
  • Seek Professional Advice: Engage financial advisors or turnaround specialists to plan restructuring or recovery strategies.
  • Enhance Transparency: Even if not required, consider voluntary audit or more detailed financial reporting to reassure stakeholders and improve governance.
  • Explore Funding Options: Investigate loans, grants, or equity financing to support growth or turnaround efforts.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.